News

Vaccine Trials Initiated in Brazil and South Africa

Vaccine Trials Initiated in Brazil and South Africa

Trials to assess the COVID-19 vaccine candidate, ChAdOx1 nCoV-19 (AZD1222), developed by the University of Oxford and licensed to AstraZeneca have kicked off in South Africa and Brazil. Trial participants include 2,000 health workers in Sao Paulo and 1,000 people in Rio de Janeiro. The trial will be South Africa’s first for coronavirus. Yourway has an advanced global depot network, with hubs in Sao Paulo and Johannesburg.

Back to Index
Media

Upcoming Event

Clinical Operations in Oncology Trials East Coast 2020

July 15-16, 2020
Boston, MA, USA (Virtual)

Media

Articles

SUPPLY CHAIN SOLUTIONS – Storage and Distribution Support for Clinical Trials Worldwide

Open chat
Come chat with us!
Hello! How can I help you?